Insider Trades165 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 479,700 | $76.86 | $28.3B | -39.17% | +43.17% | $36.9M | +0.00% | — | Stalk |
| Aug 6, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 54,346 | $74.91 | $28.3B | -39.17% | +43.17% | $4.1M | +0.00% | 10b5-1 | Stalk |
| Jul 23, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,400 | $65.50 | $28.3B | -39.17% | +43.17% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Jul 9, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $71.17 | $28.3B | -39.17% | +43.17% | $1.5M | +0.00% | 10b5-1 | Stalk |
| Jul 6, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 24,604 | $67.89 | $28.3B | -39.17% | +43.17% | $1.7M | +0.00% | 10b5-1 | Stalk |
| Jun 25, 2026 | Sell | INSM | William Lewis | Chair and CEO | 42,796 | $64.13 | $28.3B | -39.17% | +43.17% | $2.7M | +0.00% | 10b5-1 | Stalk |
| Jun 22, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 1,806 | $95.82 | $28.3B | -39.17% | +43.17% | $173.1K | -4.58% | 10b5-1 | Stalk |
| Jun 8, 2026 | Sell | INSM | William Lewis | Chair and CEO | 6,515 | $94.03 | $28.3B | -39.17% | +43.17% | $612.6K | -2.45% | 10b5-1 | Stalk |
| Jun 3, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 2,159 | $102.27 | $28.3B | -39.17% | +43.17% | $220.8K | -5.19% | — | Stalk |
| Jun 3, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 2,370 | $102.27 | $28.3B | -39.17% | +43.17% | $242.4K | -2.35% | — | Stalk |
| Jun 3, 2026 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 2,404 | $102.27 | $28.3B | -39.17% | +43.17% | $245.9K | -3.36% | — | Stalk |
| Jun 3, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 4,424 | $102.90 | $28.3B | -39.17% | +43.17% | $455.2K | -3.48% | 10b5-1 | Stalk |
| Jun 3, 2026 | Sell | INSM | William Lewis | Chair and CEO | 7,605 | $102.27 | $28.3B | -39.17% | +43.17% | $777.8K | -2.79% | — | Stalk |
| May 22, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 6,149 | $108.47 | $28.3B | -39.17% | +43.17% | $667.0K | -12.87% | 10b5-1 | Stalk |
| May 18, 2026 | Sell | INSM | William Lewis | Chair and CEO | 36,263 | $82.32 | $28.3B | -39.17% | +43.17% | $3.0M | -0.99% | 10b5-1 | Stalk |
| May 13, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 4,109 | $116.18 | $28.3B | -39.17% | +43.17% | $477.4K | -7.92% | — | Stalk |
| May 13, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 5,837 | $116.18 | $28.3B | -39.17% | +43.17% | $678.1K | -5.46% | — | Stalk |
| May 13, 2026 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 8,272 | $116.18 | $28.3B | -39.17% | +43.17% | $961.0K | -10.37% | — | Stalk |
| May 13, 2026 | Sell | INSM | William Lewis | Chair and CEO | 13,283 | $116.18 | $28.3B | -39.17% | +43.17% | $1.5M | -4.41% | — | Stalk |
| May 13, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 18,333 | $116.12 | $28.3B | -39.17% | +43.17% | $2.1M | -7.72% | 10b5-1 | Stalk |
| May 11, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 25,898 | $58.74 | $28.3B | -39.17% | +43.17% | $1.5M | +0.00% | 10b5-1 | Stalk |
| May 4, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $81.14 | $28.3B | -39.17% | +43.17% | $1.7M | +0.00% | 10b5-1 | Stalk |
| Apr 16, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $84.46 | $28.3B | -39.17% | +43.17% | $1.8M | +0.00% | 10b5-1 | Stalk |
| Apr 6, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $94.08 | $28.3B | -39.17% | +43.17% | $2.0M | +0.00% | 10b5-1 | Stalk |
| Apr 1, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 176,120 | $89.60 | $28.3B | -39.17% | +43.17% | $15.8M | +0.00% | 10b5-1 | Stalk |
| Mar 30, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 39,276 | $87.88 | $28.3B | -39.17% | +43.17% | $3.5M | +0.00% | 10b5-1 | Stalk |
| Mar 19, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $84.23 | $28.3B | -39.17% | +43.17% | $1.8M | +0.00% | 10b5-1 | Stalk |
| Mar 5, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $85.48 | $28.3B | -39.17% | +43.17% | $1.8M | +0.00% | 10b5-1 | Stalk |
| Feb 24, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 45,022 | $93.39 | $28.3B | -39.17% | +43.17% | $4.2M | -1.58% | 10b5-1 | Stalk |
| Feb 19, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $87.96 | $28.3B | -39.17% | +43.17% | $1.9M | +0.00% | 10b5-1 | Stalk |
| Feb 9, 2026 | Sell | INSM | William Lewis | Chair and CEO | 24,095 | $93.24 | $28.3B | -39.17% | +43.17% | $2.2M | -0.16% | 10b5-1 | Stalk |
| Feb 5, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 869 | $152.44 | $28.3B | -39.17% | +43.17% | $132.5K | -1.03% | 10b5-1 | Stalk |
| Feb 3, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 640 | $156.27 | $28.3B | -39.17% | +43.17% | $100.0K | -1.12% | — | Stalk |
| Feb 3, 2026 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 748 | $156.34 | $28.3B | -39.17% | +43.17% | $116.9K | -0.93% | — | Stalk |
| Feb 3, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 791 | $156.17 | $28.3B | -39.17% | +43.17% | $123.5K | -0.74% | — | Stalk |
| Feb 3, 2026 | Sell | INSM | William Lewis | Chair and CEO | 3,009 | $156.34 | $28.3B | -39.17% | +43.17% | $470.4K | -0.98% | — | Stalk |
| Feb 2, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 16,759 | $112.32 | $28.3B | -39.17% | +43.17% | $1.9M | -0.12% | 10b5-1 | Stalk |
| Jan 20, 2026 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $91.94 | $28.3B | -39.17% | +43.17% | $2.0M | +0.00% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | INSM | William Lewis | Chair and CEO | 29,914 | $117.48 | $28.3B | -39.17% | +43.17% | $3.5M | -0.29% | 10b5-1 | Stalk |
| Jan 9, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 1,887 | $186.19 | $28.3B | -39.17% | +43.17% | $351.3K | -2.17% | 10b5-1 | Stalk |
| Jan 6, 2026 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 3,158 | $174.00 | $28.3B | -39.17% | +43.17% | $549.5K | -1.78% | — | Stalk |
| Jan 6, 2026 | Sell | INSM | Roger Adsett | Chief Operating Officer | 4,290 | $174.06 | $28.3B | -39.17% | +43.17% | $746.7K | -1.29% | — | Stalk |
| Jan 6, 2026 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 4,642 | $174.22 | $28.3B | -39.17% | +43.17% | $808.7K | -1.85% | — | Stalk |
| Jan 6, 2026 | Sell | INSM | William Lewis | Chair and CEO | 9,676 | $174.03 | $28.3B | -39.17% | +43.17% | $1.7M | -1.00% | — | Stalk |
| Jan 6, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 25,100 | $123.65 | $28.3B | -39.17% | +43.17% | $3.1M | -1.04% | 10b5-1 | Stalk |
| Jan 5, 2026 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 24,606 | $98.59 | $28.3B | -39.17% | +43.17% | $2.4M | +0.00% | 10b5-1 | Stalk |
| Jan 2, 2026 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 174,580 | $94.56 | $28.3B | -39.17% | +43.17% | $16.5M | +0.00% | 10b5-1 | Stalk |
| Dec 18, 2025 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $95.96 | $28.3B | -39.17% | +43.17% | $2.1M | +0.00% | 10b5-1 | Stalk |
| Dec 4, 2025 | Sell | INSM | William Lewis | Chair and CEO | 21,398 | $115.28 | $28.3B | -39.17% | +43.17% | $2.5M | +0.00% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 17,790 | $116.41 | $28.3B | -39.17% | +43.17% | $2.1M | +0.00% | 10b5-1 | Stalk |
| Nov 12, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 60,000 | $110.23 | $28.3B | -39.17% | +43.17% | $6.6M | +0.00% | — | Stalk |
| Nov 11, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 62,452 | $103.92 | $28.3B | -39.17% | +43.17% | $6.5M | +0.00% | 10b5-1 | Stalk |
| Nov 3, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 54,260 | $103.76 | $28.3B | -39.17% | +43.17% | $5.6M | +0.00% | 10b5-1 | Stalk |
| Sep 12, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 133,040 | $93.75 | $28.3B | -39.17% | +43.17% | $12.5M | -5.83% | 10b5-1 | Stalk |
| Sep 4, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 23,303 | $142.53 | $28.3B | -39.17% | +43.17% | $3.3M | -29.21% | — | Stalk |
| Sep 2, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 37,052 | $104.76 | $28.3B | -39.17% | +43.17% | $3.9M | -2.36% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 373,296 | $83.87 | $28.3B | -39.17% | +43.17% | $31.3M | +0.00% | 10b5-1 | Stalk |
| Aug 19, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 25,000 | $127.58 | $28.3B | -39.17% | +43.17% | $3.2M | -10.37% | — | Stalk |
| Aug 18, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,730 | $69.63 | $28.3B | -39.17% | +43.17% | $956.0K | +0.00% | 10b5-1 | Stalk |
| Aug 14, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 10,000 | $127.34 | $28.3B | -39.17% | +43.17% | $1.3M | -3.90% | — | Stalk |
| Aug 4, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $60.33 | $28.3B | -39.17% | +43.17% | $824.1K | +0.00% | 10b5-1 | Stalk |
| Aug 4, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 17,430 | $64.62 | $28.3B | -39.17% | +43.17% | $1.1M | +0.00% | 10b5-1 | Stalk |
| Jul 21, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 106,288 | $70.21 | $28.3B | -39.17% | +43.17% | $7.5M | -1.56% | 10b5-1 | Stalk |
| Jul 15, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $56.61 | $28.3B | -39.17% | +43.17% | $773.3K | +0.00% | 10b5-1 | Stalk |
| Jul 11, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 1,681 | $99.80 | $28.3B | -39.17% | +43.17% | $167.8K | -1.24% | 10b5-1 | Stalk |
| Jul 7, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 105,652 | $63.93 | $28.3B | -39.17% | +43.17% | $6.8M | -1.37% | 10b5-1 | Stalk |
| Jul 1, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $54.59 | $28.3B | -39.17% | +43.17% | $745.7K | +0.00% | 10b5-1 | Stalk |
| Jun 23, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 105,654 | $64.33 | $28.3B | -39.17% | +43.17% | $6.8M | -1.59% | 10b5-1 | Stalk |
| Jun 16, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 10,686 | $98.82 | $28.3B | -39.17% | +43.17% | $1.1M | -3.87% | 10b5-1 | Stalk |
| Jun 16, 2025 | Sell | INSM | William Lewis | Chair and CEO | 264,814 | $56.50 | $28.3B | -39.17% | +43.17% | $15.0M | -0.19% | 10b5-1 | Stalk |
| Jun 10, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 90,326 | $56.79 | $28.3B | -39.17% | +43.17% | $5.1M | +0.00% | 10b5-1 | Stalk |
| Jun 10, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 105,656 | $56.89 | $28.3B | -39.17% | +43.17% | $6.0M | -0.81% | 10b5-1 | Stalk |
| Jun 10, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 245,772 | $58.14 | $28.3B | -39.17% | +43.17% | $14.3M | -2.49% | 10b5-1 | Stalk |
| Jun 5, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 1,879 | $73.50 | $28.3B | -39.17% | +43.17% | $138.1K | -2.70% | 10b5-1 | Stalk |
| Jun 3, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 1,448 | $71.50 | $28.3B | -39.17% | +43.17% | $103.5K | -2.04% | — | Stalk |
| Jun 3, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 1,579 | $71.50 | $28.3B | -39.17% | +43.17% | $112.9K | -1.37% | — | Stalk |
| Jun 3, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 1,642 | $71.50 | $28.3B | -39.17% | +43.17% | $117.4K | -1.37% | — | Stalk |
| Jun 3, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 1,686 | $71.50 | $28.3B | -39.17% | +43.17% | $120.5K | -1.99% | — | Stalk |
| Jun 3, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 1,860 | $71.50 | $28.3B | -39.17% | +43.17% | $133.0K | -1.30% | — | Stalk |
| Jun 2, 2025 | Sell | INSM | William Lewis | Chair and CEO | 19,132 | $49.78 | $28.3B | -39.17% | +43.17% | $952.4K | -0.39% | 10b5-1 | Stalk |
| May 30, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 26,327 | $69.65 | $28.3B | -39.17% | +43.17% | $1.8M | -13.97% | 10b5-1 | Stalk |
| May 20, 2025 | Sell | INSM | William Lewis | Chair and CEO | 34,717 | $56.49 | $28.3B | -39.17% | +43.17% | $2.0M | -1.01% | 10b5-1 | Stalk |
| May 15, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 11,724 | $65.79 | $28.3B | -39.17% | +43.17% | $771.3K | -5.46% | 10b5-1 | Stalk |
| May 13, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 4,816 | $67.62 | $28.3B | -39.17% | +43.17% | $325.7K | -2.55% | — | Stalk |
| May 13, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 6,235 | $67.37 | $28.3B | -39.17% | +43.17% | $420.1K | -2.63% | — | Stalk |
| May 13, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 9,407 | $67.36 | $28.3B | -39.17% | +43.17% | $633.7K | -3.30% | — | Stalk |
| May 13, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 10,152 | $67.43 | $28.3B | -39.17% | +43.17% | $684.6K | -5.29% | — | Stalk |
| May 13, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 10,504 | $67.47 | $28.3B | -39.17% | +43.17% | $708.7K | -4.59% | — | Stalk |
| May 13, 2025 | Sell | INSM | William Lewis | Chair and CEO | 21,213 | $66.73 | $28.3B | -39.17% | +43.17% | $1.4M | -2.17% | — | Stalk |
| May 1, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $41.71 | $28.3B | -39.17% | +43.17% | $569.8K | +0.00% | 10b5-1 | Stalk |
| Apr 15, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $40.50 | $28.3B | -39.17% | +43.17% | $553.3K | +0.00% | 10b5-1 | Stalk |
| Apr 1, 2025 | Sell | INSM | William Lewis | Chair and CEO | 13,660 | $42.22 | $28.3B | -39.17% | +43.17% | $576.7K | +0.00% | 10b5-1 | Stalk |
| Mar 17, 2025 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $48.30 | $28.3B | -39.17% | +43.17% | $2.5M | +0.00% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $48.68 | $28.3B | -39.17% | +43.17% | $2.5M | +0.00% | 10b5-1 | Stalk |
| Feb 18, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 18,322 | $80.31 | $28.3B | -39.17% | +43.17% | $1.5M | -7.14% | 10b5-1 | Stalk |
| Feb 18, 2025 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $50.30 | $28.3B | -39.17% | +43.17% | $2.6M | +0.00% | 10b5-1 | Stalk |
| Feb 11, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 18,321 | $80.00 | $28.3B | -39.17% | +43.17% | $1.5M | -6.15% | 10b5-1 | Stalk |
| Feb 10, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 37,828 | $78.61 | $28.3B | -39.17% | +43.17% | $3.0M | -9.71% | 10b5-1 | Stalk |
| Feb 10, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 42,975 | $78.61 | $28.3B | -39.17% | +43.17% | $3.4M | -7.97% | 10b5-1 | Stalk |
| Feb 6, 2025 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 7,920 | $80.90 | $28.3B | -39.17% | +43.17% | $640.7K | -2.89% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 20,650 | $80.90 | $28.3B | -39.17% | +43.17% | $1.7M | -17.61% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 23,500 | $80.90 | $28.3B | -39.17% | +43.17% | $1.9M | -16.28% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 28,390 | $80.90 | $28.3B | -39.17% | +43.17% | $2.3M | -15.44% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 33,115 | $80.90 | $28.3B | -39.17% | +43.17% | $2.7M | -10.71% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 45,705 | $80.90 | $28.3B | -39.17% | +43.17% | $3.7M | -10.78% | — | Stalk |
| Feb 6, 2025 | Sell | INSM | William Lewis | Chair and CEO | 79,350 | $80.90 | $28.3B | -39.17% | +43.17% | $6.4M | -14.88% | — | Stalk |
| Feb 3, 2025 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $48.76 | $28.3B | -39.17% | +43.17% | $2.5M | +0.00% | 10b5-1 | Stalk |
| Jan 30, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 182,280 | $47.52 | $28.3B | -39.17% | +43.17% | $8.7M | +0.00% | 10b5-1 | Stalk |
| Jan 15, 2025 | Sell | INSM | William Lewis | Chair and CEO | 64,215 | $50.02 | $28.3B | -39.17% | +43.17% | $3.2M | -0.46% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 872 | $68.72 | $28.3B | -39.17% | +43.17% | $59.9K | -0.89% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 1,384 | $68.72 | $28.3B | -39.17% | +43.17% | $95.1K | -1.36% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 1,457 | $68.72 | $28.3B | -39.17% | +43.17% | $100.1K | -0.99% | 10b5-1 | Stalk |
| Jan 7, 2025 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 3,689 | $65.82 | $28.3B | -39.17% | +43.17% | $242.8K | -1.60% | — | Stalk |
| Jan 7, 2025 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 6,000 | $65.43 | $28.3B | -39.17% | +43.17% | $392.6K | -1.56% | — | Stalk |
| Jan 7, 2025 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 7,862 | $64.74 | $28.3B | -39.17% | +43.17% | $509.0K | -1.84% | 10b5-1 | Stalk |
| Jan 7, 2025 | Sell | INSM | Roger Adsett | Chief Operating Officer | 9,228 | $64.78 | $28.3B | -39.17% | +43.17% | $597.8K | -1.46% | 10b5-1 | Stalk |
| Jan 7, 2025 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 11,218 | $64.70 | $28.3B | -39.17% | +43.17% | $725.8K | -2.47% | 10b5-1 | Stalk |
| Jan 7, 2025 | Sell | INSM | William Lewis | Chair and CEO | 15,195 | $65.48 | $28.3B | -39.17% | +43.17% | $995.0K | -1.20% | — | Stalk |
| Jan 7, 2025 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 23,587 | $44.80 | $28.3B | -39.17% | +43.17% | $1.1M | -0.55% | 10b5-1 | Stalk |
| Jan 2, 2025 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $44.71 | $28.3B | -39.17% | +43.17% | $2.3M | +0.00% | 10b5-1 | Stalk |
| Dec 19, 2024 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $44.75 | $28.3B | -39.17% | +43.17% | $2.3M | +0.00% | 10b5-1 | Stalk |
| Dec 12, 2024 | Sell | INSM | William Lewis | Chair and CEO | 51,160 | $46.28 | $28.3B | -39.17% | +43.17% | $2.4M | +0.00% | 10b5-1 | Stalk |
| Sep 13, 2024 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 34,871 | $63.99 | $28.3B | -39.17% | +43.17% | $2.2M | -7.99% | 10b5-1 | Stalk |
| Sep 12, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 82,080 | $54.47 | $28.3B | -39.17% | +43.17% | $4.5M | +0.00% | 10b5-1 | Stalk |
| Sep 10, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 75,150 | $41.18 | $28.3B | -39.17% | +43.17% | $3.1M | +0.00% | 10b5-1 | Stalk |
| Sep 6, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 298,004 | $47.00 | $28.3B | -39.17% | +43.17% | $14.0M | +0.00% | 10b5-1 | Stalk |
| Aug 12, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 9,469 | $72.49 | $28.3B | -39.17% | +43.17% | $686.4K | -8.64% | — | Stalk |
| Aug 12, 2024 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 176,140 | $44.27 | $28.3B | -39.17% | +43.17% | $7.8M | +0.00% | — | Stalk |
| Jul 8, 2024 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 730 | $70.05 | $28.3B | -39.17% | +43.17% | $51.1K | -0.82% | — | Stalk |
| Jun 10, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 42,390 | $41.88 | $28.3B | -39.17% | +43.17% | $1.8M | +0.00% | 10b5-1 | Stalk |
| Jun 3, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 110,000 | $38.21 | $28.3B | -39.17% | +43.17% | $4.2M | +0.00% | 10b5-1 | Stalk |
| May 28, 2024 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 14,102 | $33.30 | $28.3B | -39.17% | +43.17% | $469.5K | -0.43% | 10b5-1 | Stalk |
| May 28, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 55,000 | $31.05 | $28.3B | -39.17% | +43.17% | $1.7M | +0.00% | 10b5-1 | Stalk |
| May 28, 2024 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 83,693 | $33.11 | $28.3B | -39.17% | +43.17% | $2.8M | -0.85% | 10b5-1 | Stalk |
| May 28, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 250,002 | $37.10 | $28.3B | -39.17% | +43.17% | $9.3M | +0.00% | 10b5-1 | Stalk |
| May 28, 2024 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 482,576 | $38.27 | $28.3B | -39.17% | +43.17% | $18.5M | +0.00% | 10b5-1 | Stalk |
| May 17, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 4,642 | $25.09 | $28.3B | -39.17% | +43.17% | $116.5K | -4.19% | 10b5-1 | Stalk |
| May 17, 2024 | Sell | INSM | Roger Adsett | Chief Operating Officer | 5,945 | $25.09 | $28.3B | -39.17% | +43.17% | $149.2K | -3.83% | 10b5-1 | Stalk |
| May 14, 2024 | Sell | INSM | Michael Alexander Smith | Chief Legal Officer | 5,093 | $25.40 | $28.3B | -39.17% | +43.17% | $129.4K | -3.09% | — | Stalk |
| May 14, 2024 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 5,088 | $25.47 | $28.3B | -39.17% | +43.17% | $129.6K | -2.55% | — | Stalk |
| May 14, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 6,508 | $25.53 | $28.3B | -39.17% | +43.17% | $166.1K | -3.61% | — | Stalk |
| May 14, 2024 | Sell | INSM | Roger Adsett | Chief Operating Officer | 7,857 | $25.50 | $28.3B | -39.17% | +43.17% | $200.4K | -3.35% | — | Stalk |
| May 14, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 10,640 | $25.47 | $28.3B | -39.17% | +43.17% | $271.0K | -5.53% | — | Stalk |
| May 14, 2024 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 11,088 | $25.32 | $28.3B | -39.17% | +43.17% | $280.7K | -5.55% | — | Stalk |
| May 14, 2024 | Sell | INSM | William Lewis | Chair and CEO | 22,198 | $25.52 | $28.3B | -39.17% | +43.17% | $566.5K | -3.61% | — | Stalk |
| Feb 28, 2024 | Buy | INSM | William Lewis | Chair and CEO | 50,000 | $12.58 | $28.3B | -39.17% | +43.17% | $629.0K | +10000.00% | — | Stalk |
| Jan 12, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 4,667 | $28.63 | $28.3B | -39.17% | +43.17% | $133.6K | -4.18% | 10b5-1 | Stalk |
| Jan 12, 2024 | Sell | INSM | Roger Adsett | Chief Operating Officer | 5,251 | $28.63 | $28.3B | -39.17% | +43.17% | $150.3K | -3.41% | 10b5-1 | Stalk |
| Jan 9, 2024 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 1,861 | $28.78 | $28.3B | -39.17% | +43.17% | $53.6K | -1.61% | — | Stalk |
| Jan 9, 2024 | Sell | INSM | Michael Alexander Smith | General Counsel, Senior VP | 2,373 | $28.76 | $28.3B | -39.17% | +43.17% | $68.2K | -2.67% | — | Stalk |
| Jan 9, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 4,171 | $27.84 | $28.3B | -39.17% | +43.17% | $116.1K | -1.00% | 10b5-1 | Stalk |
| Jan 9, 2024 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 4,497 | $29.18 | $28.3B | -39.17% | +43.17% | $131.2K | -3.79% | — | Stalk |
| Jan 9, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 5,960 | $28.99 | $28.3B | -39.17% | +43.17% | $172.8K | -2.59% | 10b5-1 | Stalk |
| Jan 9, 2024 | Sell | INSM | Roger Adsett | Chief Operating Officer | 7,373 | $29.08 | $28.3B | -39.17% | +43.17% | $214.4K | -2.31% | 10b5-1 | Stalk |
| Jan 8, 2024 | Sell | INSM | William Lewis | Chair and CEO | 100,127 | $25.34 | $28.3B | -39.17% | +43.17% | $2.5M | -0.52% | 10b5-1 | Stalk |
| Jan 5, 2024 | Sell | INSM | Michael Alexander Smith | General Counsel, Senior VP | 627 | $29.30 | $28.3B | -39.17% | +43.17% | $18.4K | -0.42% | — | Stalk |
| Jan 5, 2024 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 1,386 | $29.20 | $28.3B | -39.17% | +43.17% | $40.5K | -0.76% | — | Stalk |
| Jan 5, 2024 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 1,457 | $29.28 | $28.3B | -39.17% | +43.17% | $42.7K | -0.88% | — | Stalk |
| Jan 5, 2024 | Sell | INSM | Roger Adsett | Chief Operating Officer | 3,042 | $29.21 | $28.3B | -39.17% | +43.17% | $88.9K | -1.34% | — | Stalk |
| Jan 5, 2024 | Sell | INSM | William Lewis | Chair and CEO | 6,979 | $29.26 | $28.3B | -39.17% | +43.17% | $204.2K | -1.23% | — | Stalk |
| Jan 3, 2024 | Sell | INSM | John Drayton Wise | Chief Commercial Officer | 41,309 | $24.30 | $28.3B | -39.17% | +43.17% | $1.0M | -0.29% | 10b5-1 | Stalk |
| Dec 28, 2023 | Sell | INSM | Orlov S Nicole Schaeffer | Chief People Strategy Officer | 44,576 | $26.24 | $28.3B | -39.17% | +43.17% | $1.2M | +0.00% | 10b5-1 | Stalk |
| Dec 22, 2023 | Sell | INSM | Sara Bonstein | Chief Financial Officer | 13,199 | $30.00 | $28.3B | -39.17% | +43.17% | $396.0K | -11.14% | 10b5-1 | Stalk |
| Dec 22, 2023 | Sell | INSM | Martina M.D. Flammer | Chief Medical Officer | 56,620 | $26.83 | $28.3B | -39.17% | +43.17% | $1.5M | +0.00% | 10b5-1 | Stalk |
| Oct 27, 2023 | Buy | INSM | William Lewis | Chair and CEO | 224,500 | $19.15 | $28.3B | -39.17% | +43.17% | $4.3M | +0.03% | 10b5-1 | Stalk |